Cell transplantation for Parkinson's disease

Neurological Research

Volumn 26, Issue 4, 2004, Pages 355-362

  Roitberg, Ben ^a   Urbaniak, Klaudia ^a   Emborg, Marina ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH UNIVERSITY   (United States)

Author keywords

Clinical trials; Fetal cell transplantation; Parkinson's disease; Stem cells

Indexed keywords

DOPAMINE;

ARTICLE; CELL TRANSPLANTATION; CLINICAL TRIAL; CORPUS STRIATUM; DEGENERATIVE DISEASE; DISEASE COURSE; DOPAMINERGIC NERVE CELL; FETUS CELL; HUMAN; NERVE GRAFT; NONHUMAN; PARKINSON DISEASE; STEM CELL; SUBSTANTIA NIGRA;

ANIMALS; BRAIN; CELL TRANSPLANTATION; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; FETAL TISSUE TRANSPLANTATION; HUMANS; PARKINSON DISEASE; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTS;

EID: 2942526898     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164104225017604     Document Type: Article

References (62)

1. Goetz CG. Textbook of Clinical Neurology, 2nd edn. W. B. Saunders Co., Philadelphia, PA, 1999
2. Baron MS, Vitek JL, Bakay RA, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996; 40: 355-366
3. Narabayashi H. Physiological analysis of ventrolateral thalamotomy for rigidity and tremor. Confin Neurol 1965; 26: 264-268
4. Esselink RA, de Bie RM, de Haan RJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: A randomized trial. Neurology 2004; 62: 201-207
5. Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 1968; 5: 107-110
6. Bjorklund A, Stenevi U. Growth of central catecholamine neurones into smooth muscle grafts in the rat mesencephalon. Brain Res 1971; 31: 1-20
7. Madrazo I, Drucker-Colin R, Diaz V, et al. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N Engl J Med 1987; 316: 831-834
8. Bakay RA, Watts RL, Freeman A, et al. Preliminary report on adrenal-brain transplantation for parkinsonism in man. Stereotact Funct Neurosurg 1990; 54/55: 312-323
9. Brundin P, Nilsson OG, Strecker RE, et al. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res 1986; 65: 235-240
10. Burns RS, Chiueh CC, Markey SP, et al. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 1983; 80: 4546-4550
11. Lindvall O, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990; 247: 574-577
12. Lindvall O, Sawle G, Widner H, et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 1994; 35: 172-180
13. Freed CR, Breeze RE, Rosenberg NL, et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 1992; 327: 1549-1555
14. Hagell P, Crabb L, Pogarell O, et al. Health-related quality of life following bilateral intrastriatal transplantation in Parkinson' disease. Mov Disord 2000; 15: 224-229
15. Brundin P, Pogarell O, Hagell P, et al. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson' disease. Brain 2000; 123 (Pt 7): 1380-1390
16. Hitchcock ER, Clough C, Hughes R, et al. Embryos and Parkinson's disease. Lancet 1988; 1: 1274
17. Kordower JH, Freeman TB, Snow BJ, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 1995; 332: 1118-1124
18. Freeman TB, Olanow CW, Hauser RA, et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson' disease. Ann Neurol 1995; 38: 379-388
19. Redmond DE Jr. Cellular replacement therapy for Parkinson's disease - where we are today? Neuroscientist 2002; 8: 457-488
20. Kordower JH, Styren S, Clarke M, et al. Fetal grafting for Parkinson's disease: Expression of immune markers in two patients with functional fetal nigral implants. Cell Transplant 1997; 6: 213-219
21. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001; 344: 710-719
22. Olanow CW, Goetz CG, Kordower JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003; 54: 403-414
23. Dunning JJ, White DJ, Wallwork J. The rationale for xenotransplantation as a solution to the donor organ shortage. Pathol Biol 1994; 42: 231-345
24. Galpern WR, Burns LH, Deacon TW, et al. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: Functional recovery and graft morphology. Exp Neurol 1996; 140: 1-13
25. Schumacher JM, Ellias SA, Palmer EP, et al. Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 2000; 54: 1042-1050
26. Freeman TB. A prospective, randomized, double-blind, surgical placebo-controlled trial of intrastriatal transplantation of fetal porcine ventral mesencephalic tissue (Neurocell-PD) in subjects with Parkinson's disease (Abstract). 8th International Conference on Neural Transplantation and Repair. Keystone, CO, 2002
27. Nakao N, Kakishita K, Uematsu Y, et al. Enhancement of the response to levodopa therapy after intrastriatal transplantation of autologous sympathetic neurons in patients with Parkinson disease. J Neurosurg 2001; 95: 275-284
28. Itakura T, Uematsu Y, Nakao N, et al. Transplantation of autologous sympathetic ganglion into the brain with Parkinson's disease. Long-term follow-up of 35 cases. Stereotact Funct Neurosurg 1997; 69 (1-4 Pt 2): 112-115
29. Watts RL, Subramanian T, Freeman A, et al. Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: Two-year follow-up study. Exp Neurol 1997; 147: 510-517
30. Willing AE, Othberg AI, Saporta S, et al. Sertoli cells enhance the survival of co-transplanted dopamine neurons. Brain Res 1999; 822: 246-250
31. López-Barneo J, Pardal R, Ortega-Sáenz P. Cellular mechanism of oxygen sensing. Annu Rev Physiol 2001; 63: 259-287
32. Toledo-Aral JJ, Méndez-Ferrer S, Pardal R, et al. Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted parkinsonian rats. J Neurosci 2003; 23: 141-148
33. Pawelek JM, Korner AM. The biosynthesis of mammalian melanin. Am Sci 1982; 70: 136-145
34. Arjona V, Minguez-Castellanos A, Montoro RJ, et al. Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease. Neurosurgery 2003; 53: 321-330
35. Itakura T, Uematsu Y, Nakao N, et al. Transplantation of autologous sympathetic ganglion into the brain with Parkinson's disease. Long-term follow-up of 35 cases. Stereotact Funct Neurosurg 1997; 69 (1-4 Pt 2): 112-115
36. Potter BM, Kidwell W, Cornfeldt M. 27th Annual Meeting for Neuroscience, New Orleans, LA, 1997: (Abstract) 778.10
37. Marchionini DM, Subramanian T, Burnette B, et al. American Society for Neural Transplantation Annual Meeting, Clearwater FL, 1999: (Abstract) A-05
38. Subramanian T, Marchionini D, Potter EM, et al. Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response. Cell Transplant 2002; 11: 207-214
39. Doudet D, Honey C, Schweikert AWm, et al. Abstract at the 8th International Conference on Neural Transplantation and Repair. Keystone, CO, 2002
40. Watts RL, Raiser CD, Stover NP, et al. Stereotaxic intrastriatal implantation of retinal pigment epithelial cells attached to microcarriers in advanced Parkinson's disease (PD) patients: A pilot study in six patients. Parkinsonism Related Disord 2001; 7 (Supple.): S87
41. Bakay RA, Raiser CD, Stover NP, et al. Implantation of Spheramine in advanced Parkinson's disease (PD). Front Biosci 2004; 9: 592-602
42. Deacon T, Dinsmore J, Costantini LC, et al. Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation. Exp Neurol 1998; 149: 28-41
43. Wilson PA, Hemmati-Brivanlou A. Vertebrate neural induction: Inducers, inhibitors, and a new synthesis. Neuron 1997; 18: 699-710
44. Hemmati-Brivanlou A, Melton D. Vertebrate embryonic cells will become nerve cells unless told otherwise. Cell 1997; 88: 13-17
45. Tropepe V, Hitoshi S, Sirard C, et al. Direct neural fate specification from embryonic stem cells: A primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 2001; 30: 65-78
46. Bjorklund LM, Sanchez-Pernaute R, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 2002; 99: 2344-2349
47. Kawasaki H, Mizuseki K, Nishikawa S, et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000; 28: 31-40
48. Alvarez-Buylla A, Garcia-Verdugo JM, Tramontin AD. A unified hypothesis on the lineage of neural stem cells. Nat Rev Neurosci 2001; 2: 287-293
49. Gage FH. Mammalian neural stem cells. Science 2000; 287: 1433-1438
50. Deng W, Obrocka M, Fischer I, et al. In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem Biophys Res Commun 2001; 282: 148-152
51. Lu D, Mahmood A, Wang L, et al. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport 2001; 12: 559-563
52. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000; 164: 247-256
53. Woodbury D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000; 61: 364-370
54. Gill SS, Patel NK, Hotton GR, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 2003; 9: 589-595
55. Shoichet MS, Winn SR. Cell delivery to the central nervous system. Adv Drug Deliv Rev 2000; 42: 81-102
56. Blanchet PJ, Konitsiotis S, Mochizuki H, et al. Complications of a trophic xenotransplant approach in parkinsonian monkeys. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 607-612
57. Kordower JH, Emborg ME, Bloch J, et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 2000; 290: 767-773
58. Annett LE, Martel FL, Rogers DC, et al. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 1994; 125: 228-246
59. Bjorklund A, Dunnett SB, Brundin P, et al. Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol 2003; 2: 437-445
60. Mura A, Mintz M, Feldon J. Behavioral and anatomical effects of long-term L-dihydroxyphenylalanine (L-DOPA) administration in rats with unilateral lesions of the nigrostriatal system. Exp Neurol 2002; 177: 252-264
61. Steece-Collier K, Collier TJ, Sladek CD, et al. Chronic levodopa impairs morphological development of grafted embryonic dopamine neurons. Exp Neurol 1990; 110: 201-208
62. Svendsen CN, Langston JW. Stem cells for Parkinson disease and ALS: Replacement or protection? Nat Med 2004; 10: 224-225